Evrofarma SA (ATH:EVROF)
3.850
+0.020 (0.52%)
Feb 18, 2026, 10:54 AM EET
92.50% (1Y)
| Market Cap | 52.37M +102.1% |
| Revenue (ttm) | 45.72M -6.2% |
| Net Income | 2.28M +3.5% |
| EPS | n/a |
| Shares Out | 13.67M |
| PE Ratio | 23.95 |
| Forward PE | n/a |
| Dividend | 0.05 (1.31%) |
| Ex-Dividend Date | Aug 19, 2025 |
| Volume | 1,798 |
| Average Volume | 4,409 |
| Open | 3.810 |
| Previous Close | 3.830 |
| Day's Range | 3.800 - 3.880 |
| 52-Week Range | 1.605 - 4.070 |
| Beta | 0.77 |
| RSI | 52.60 |
| Earnings Date | Apr 9, 2026 |